Logo Tavernier Tschanz

News

Tavernier Tschanz advised Banque SYZ SA on the acquisition of BHA Partners AG

Tavernier Tschanz advised Banque SYZ SA on the acquisition of BHA Partners AG

Deals and Cases
January 2022

Tavernier Tschanz advised the sellers in the sale of Banque Pâris Bertrand to Rothschild and Co

Tavernier Tschanz advised the sellers in the sale of Banque Pâris Bertrand to Rothschild and Co

Deals and Cases
July 2021

Tavernier Tschanz advised Sophia Genetics in its Nasdaq IPO

Tavernier Tschanz advised Sophia Genetics in its Nasdaq IPO

Deals and Cases
July 2021

Tavernier Tschanz advised Invision in the acquisition of a majority stake in Plumettaz

Tavernier Tschanz advised Invision in the acquisition of a majority stake in Plumettaz

Deals and Cases
July 2021

Tavernier Tschanz advised ClearSpace in its first financing round

Tavernier Tschanz advised ClearSpace in its first financing round

Deals and Cases
June 2021

Tavernier Tschanz advised Condis SA in its acquisition of Elvexis SA

Tavernier Tschanz advised Condis SA in its acquisition of Elvexis SA

Deals and Cases
March 2021

Tavernier Tschanz advised Sophia Genetics in its USD 110 million series F financing

Tavernier Tschanz advised Sophia Genetics in its USD 110 million series F financing

Deals and Cases
October 2020

Tavernier Tschanz advised JSR Life Sciences in the expansion of its European gene-to-GMP biologics manufacturing facilities for Selexis and KBI Biopharma

Tavernier Tschanz advised JSR Life Sciences in the expansion of its European gene-to-GMP biologics manufacturing facilities for Selexis and KBI Biopharma

Deals and Cases
October 2020

Tavernier Tschanz advised SpineArt SA in a CHF 50 million financing round

Tavernier Tschanz advised SpineArt SA in a CHF 50 million financing round

Deals and Cases
June 2020